GATOR1 Epilepsy Genetics: What a Family-Based Review Found

What was studied

Researchers conducted a family-based systematic review and meta-analysis of GATOR1-related epilepsy to examine why some people with a disease-related genetic variant are affected while others are not, and why features differ among those affected. They reconstructed individual-level information from published family trees and reassessed variants using GATOR1-specific classification criteria.

The review included 63 studies. Of these, 59 contributed data on 734 individuals from 227 families who were heterozygous for germline pathogenic or likely pathogenic GATOR1 variants. An expanded analysis also examined published cases with a germline variant and an additional somatic change in the same gene.

What they found

The pooled proportion of variant carriers reported as affected was 65.7%. Recurrent variant status, variant consequence, DEPDC5 protein domain, the transmitting parent's phenotype, and overall parental origin did not consistently distinguish affected from unaffected individuals. However, paternal DEPDC5 transmission showed an exploratory association with higher disease expression: 90.4% versus 82.4% (p = 0.032).

Among affected individuals, missense variants were associated with earlier seizure onset than loss-of-function variants: 0.67 versus 4.50 years (p = 0.002). Loss-of-function variants in the DEPDC5 LassoA domain showed exploratory associations with cognitive impairment, MRI abnormalities, and epilepsy surgery (FDR-adjusted p ≤ 0.046).

The expanded analysis identified 14 published same-gene germline-somatic second-hit cases; 85.7% had focal cortical dysplasia type IIa. Quantifiable somatic variant allele fractions for sequence-variant second hits were below 5% in all six single-region cases. Multiregion sampling in three cases showed variation across regions, including values below 1%.

Limits of the evidence

This analysis reconstructed data from published family reports rather than following an unselected group of variant carriers over time. The 65.7% pooled proportion should therefore not be treated as an exact risk for every carrier or family. The abstract does not provide confidence intervals, a detailed definition of being affected, or follow-up information. The paternal-transmission and LassoA findings were exploratory and need confirmation. The second-hit findings came from 14 published cases, with quantifiable sampling results in smaller subsets. These associations do not establish cause or provide a reliable individual prediction.

For families and caregivers

Carrying a pathogenic or likely pathogenic GATOR1 variant does not always mean a person will be affected. The findings suggest that predicting whether disease is expressed and predicting its features after onset are partly different questions. Some variant features were associated with differences among affected people, but they did not provide a dependable individual forecast. The second-hit findings also show that somatic changes can be present at very low measured levels and vary across sampled tissue regions.

What to watch next

Larger studies that follow families over time could help test the exploratory findings and clarify how well these patterns predict whether epilepsy develops and how it presents.

Terms in this summary

Germline variant

A genetic change present from conception, generally throughout the body, that can be passed to children.

Incomplete penetrance

When some people carrying a disease-related genetic variant do not develop the associated condition.

Missense variant

A genetic change that alters one building block of a protein.

Loss-of-function variant

A genetic variant classified as expected to reduce or disrupt normal gene function.

Somatic second hit

An additional genetic change that arises after conception in some cells, here in the same gene as the germline variant.

Variant allele fraction

The percentage of measured copies of a gene in a sample that carry a particular variant.

Focal cortical dysplasia type IIa

A specific pattern of abnormal development in a localized area of the brain's outer layer, identified by examining tissue.

FDR adjustment

A statistical adjustment used when testing multiple associations to control the expected proportion of false discoveries among findings considered significant.